SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-18-037200
Filing Date
2018-06-12
Accepted
2018-06-12 15:03:30
Documents
1
Period of Report
2018-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 2371
  Complete submission text file 0001209191-18-037200.txt   3769
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Issuer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 77 KING STREET WEST SUITE 3000 TORONTO A6 M5K 1G8
Business Address
Waldin Jan-Paul (Reporting) CIK: 0001733176 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-37347 | Film No.: 18894322